Hookworm Infection
20
1
1
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.0%
1 terminated out of 20 trials
93.8%
+7.2% vs benchmark
15%
3 trials in Phase 3/4
33%
5 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (20)
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
Safety and Immunogenicity Study of Na-GST-1 With or Without CpG
Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura
Evaluating Impact of Improved Floors on Health
Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant
Hookworm Immune Regulation Project
Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese Adults
Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian Adults
Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults
Prevalence of Hookworm Infection and Community Preparedness for Hookworm Vaccine Trials in Endemic Areas of Brazil
Triple Combinations Against Hookworm Infections in Lao
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults
Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection
Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults
Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults
Development of a Skin Test for the Na-ASP-2 Hookworm Antigen
Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm Infections